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Introduction
For peripheral pulmonary lesions, conventional ex-
aminations such as sputum analysis, bronchoscopy,
and routine chest radiographs are often limited in
disease diagnosis. Thus, image-guided percutaneous
needle biopsy (using fluoroscopy, computed tomog-
raphy, and ultrasound [US]) has been used to sample
tissues and aid in diagnosis [1–8]. Of these modal-
ities, chest US examination and US-guided needle
biopsy provide the simplest and most rapid and
convenient diagnostic tools for all lesions abutting
the chest wall [5–12]. Chest US examinations have
a number of advantages: they can be performed at
the bedside, in the patient’s most comfortable and
appropriate position (sitting, prone, or supine), and
without exposure to irradiation. In particular, im-
provements in US image resolution and the use of
a well-suited puncture-guiding device have made
US-guided needle biopsy increasingly real-time, safe,
and convenient [5,7,11]. In the literature, chest US
examinations and US-guided needle biopsy have
been shown to be valuable in diagnosing lung can-
cers, mediastinal tumors, pleural lesions, chest wall
lesions, and some peripheral pulmonary infections,
with excellent results and minimal complications
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The wide application of recent advances in chest ultrasound has enabled color Doppler
ultrasound (CDUS) to be used in evaluating thoracic lesions. Clinically, CDUS is helpful 
in assessing vessel signals within the thoracic lesions, differentiating lung cancers from
benign lesions, assessing the neovascularity of lung cancers, diagnosing congenital vascular
abnormalities (pulmonary sequestration and arteriovenous malformation), and avoiding
the complication of US-guided needle biopsy injury to the great vessels. The CDUS “fluid
color sign” can be used to detect minimal pleural effusion in thoracocentesis, and the
CDUS “pulmonary artery vessel signal” is useful in predicting pulmonary benign lesions.
Though CDUS still has some limitations in its capability to image vessel signals, the devel-
opment of power Doppler US (US angiography) has improved images of vessel signals
without angle limitation, and the newly developed dynamic flow US produces superior
imaging quality with less color noise and blooming effect. The broad application and
potential extension of CDUS in thoracic diseases has made CDUS a powerful and necessary
imaging modality in chest medicine, especially in guiding transthoracic percutaneous needle
biopsy of thoracic lesions and aiding in the differentiation of anatomic tissue.
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[5–12]. However, conventional grayscale chest US
alone is somewhat limited in the assessment of
vessel signals in thoracic lesions.
Color Doppler US (CDUS) is used for the evalu-
ation of vessel signals in normal tissues and organs
and in pathologic lesions; it has been widely used
in the cardiovascular system, abdominal lesions, ob-
stetric and gynecologic lesions, breast lesions, and
carotid and intracranial vessels [13–20]. Recently,
CDUS has also been applied in chest medicine. As
reported in the literature and from our own expe-
rience, CDUS not only clearly demonstrates the vessel
signals in thoracic lesions, but also enables assess-
ment of hemodynamic changes, tumor neovascu-
larity, congenital vascular anomalies, and anatomic
tissue differentiation [21–27]. In particular, CDUS and
its color-based puncture-guiding device readily dis-
close the prominent vessels and, therefore, signifi-
cantly increase the safety and clinical extension of
US-guided percutaneous needle biopsy [28,29]. The
development of power Doppler US (PDUS) has fur-
ther improved images of vessel signals without angle
limitation, and the newly developed dynamic flow
US (DFUS) discloses vessel signals with less color
noise and blooming effect [19,20,30,31].
In the present report, we review the published lit-
erature and describe our experience with the clinical
applications of CDUS in chest medicine.
Indications and Technique for Chest 
US and CDUS Examinations
Indications
Chest US is used initially to assess pleural effusion
and pleural opacity [32,33]. However, any pulmo-
nary lesions and mediastinal tumors abutting the
chest wall, pleural lesions, and chest wall lesions are
all suitable for chest US examination [5–12].
In usual clinical practice, a grayscale US exam-
ination is performed initially, after which CDUS
examination can be added to assess vessel signals
within the lesion. In the assessment of pulmonary
consolidations and mediastinal tumors, CDUS readily
demonstrates and evaluates the vessel signals and
can thus help prevent injury to prominent vessels
when performing transthoracic US-guided needle
biopsy [28,29].
In our experience, only a number of special con-
ditions are contraindicated for chest US examination
and US-guided needle biopsy: (1) when the patient
is not cooperative in holding his/her breath while
performing transthoracic US-guided needle biopsy
for peripheral pulmonary lesions; (2) a bleeding ten-
dency with platelets <20,000/mm3; if necessary, the
US-guided needle biopsy can be performed within
12–24 hours after platelet transfusion; (3) recent
myocardial infarction and/or unstable angina; and
(4) lesions poorly demonstrated by US.
Techniques for CDUS examination
In performing a CDUS examination, we still use
grayscale US first to localize the lesions before adding
CDUS. Before the start of the CDUS examination,
the Doppler filter is usually set at 50–100 Hz to elim-
inate low-frequency signals from vessel wall motion
and avoid interference from respiratory and cardiac
movement [13,21,24,34,35]. Color Doppler gain is
also adjusted until only a few noise specks are visible
in the background [14,24]. When the CDUS signal
is detected, the sample volume is re-adjusted to ap-
proximate the size of the detected blood vessels, and
the angle is repositioned to parallel the direction of
blood flow (the Doppler angle θ between the ul-
trasound beam and flow signal is adjusted to obtain
the largest frequency shift or velocity, while remain-
ing below 60° if possible) [14,35]. The pulse repet-
itive frequency is also adjusted, depending on the
blood flow velocity under investigation. Pulse-wave
CDUS is used to detect flow signals within the lesions;
all Doppler signal waveforms are recorded on color-
printed sonopaper and/or on laser disc, thus enabling
all data regarding the CDUS signals and spectral
waveforms of the thoracic lesions to be reviewed
and analyzed. In general, spectral waveforms that are
reproducibly similar over three consecutive cardiac
cycles are recorded as satisfactory [24,36].
CDUS is then used to assess vessel signals within
the lesions, hemodynamic changes (resistive index
[RI] and pulsatility index [PI]), tumor neovascularity,
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any special vascular anomalies, and other tissue
differentiation and clinical applications.
Applications of CDUS in 
Chest Medicine
CDUS has been used for thoracic diseases to evalu-
ate vessel signals within lesions; however, from our
perspective, the clinical applications of CDUS in chest
medicine remain underutilized. The main applica-
tions of CDUS in the published literature and clinical
practice are summarized below.
Correlation of CDUS signals with 
resected histologic specimens
CDUS has been reported as a valuable tool in
assessing the vessel signals of thoracic lesions. Hsu
et al reported their findings on the correlation of
CDUS vessel signals with resected histologic speci-
mens [21]. In their report, they found three vessel
signal flow patterns in lung cancers: pulsatile flow
(artery), triphasic flow (vein), and constant flow (Fig. 1);
only two flow patterns were present in benign
lesions: pulsatile flow and triphasic flow. In correlat-
ing CDUS vessel signals with resected histologic
specimens, constant flow was representative of the
true neovascularity of lung cancers and was valuable
in differentiating lung cancers from benign lesions
(p < 0.001). The correlation between CDUS vessel
signals and resected histologic specimens was also
excellent. Nevertheless, thoracic lesions without
CDUS vessel signals may be completely lacking in
blood vessels or have blood vessels that cannot be
detected by present-day CDUS equipment.
With increasing experience in using CDUS exami-
nations in thoracic lesions, we recently found some
pulmonary veins (often in the collapsed lung and distal
to a central endobronchial tumor) that could present
with constant flows. Thus, we should be careful in the
interpretation of CDUS constant flow vessel signals
within collapsed lungs and in some benign lesions.
CDUS pulsatile flow in the assessment of 
lung cancers and benign lesions
CDUS pulsatile flows have been used to assess and
differentiate malignancies from benign tumors, 
including breast, ovary, kidney, and other organ
Color Doppler Ultrasound in Chest Medicine
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Fig. 1. Three flow patterns of color Doppler ultrasound signals
in thoracic lesions: (A) pulsatile flow, (B) constant flow, and
(C) triphasic flow.
tumors [13–16,34–36]. In the assessment of pulsatile
flows, two parameters are often used: RI (calculated
as peak systolic velocity − end diastolic velocity/peak
systolic velocity), and PI (calculated as peak systolic
velocity − end diastolic velocity/mean velocity). Be-
cause malignancies often have sinusoid-like or large
capillary-like tumor vessels and even arteriovenous
shunts, malignancies are reported to have statistically
significantly lower RI and PI values than benign
lesions [13,14,16,34–36].
Yuan et al first reported the application of CDUS
pulsatile flows in the assessment of thoracic lesions.
In their report, RI and PI values were significant in dif-
ferentiating lung cancers from benign lesions (both
p < 0.01) [24]. However, in our experience, overlap-
ping RI and PI values between lung cancers and
benign lesions are common, thereby limiting the
application of RI and PI values in differentiating lung
cancers from benign lesions [27,37]. An interesting
finding in our series was the lower RI and PI values
in small cell lung cancers when compared with those
in non-small cell lung cancers (adenocarcinoma and
squamous cell carcinoma). The lower RI and PI values
in small cell lung cancers may imply an increasing
and intense downstream angiogenesis; conversely,
the relatively high RI and PI values in non-small cell
lung cancers probably indicate sparse angiogenesis.
Thus, compared with the clinical presentations and
biologic behavior of lung cancers, small cell lung can-
cer with intense angiogenesis has a greater range of
clinical presentations than non-small cell lung cancer;
these presentations include rapid tumor growth,
early metastasis, and sensitivity to chemotherapy.
Further study is warranted to determine whether
CDUS pulsatile flow is helpful in differentiating lung
cancers from benign lesions.
CDUS “Pulmonary Artery Vessel Signal”: 
A Sign for Predicting Benign Lesions
Lung cancers are always supplied by the bronchial
artery system; thus, pulmonary and bronchial angio-
grams were previously used to diagnose and differ-
entiate lung cancers from benign lesions. If vessel
signals within pulmonary lesions can be confirmed
to be those of the pulmonary artery, CDUS should
be able to predict and differentiate benign lesions
from lung cancers (Fig. 2).
We previously arbitrarily defined a CDUS “pul-
monary artery vessel signal” as a pulsatile flow with
a vessel signal length of ≥ 1 cm that is demonstrated
smoothly by CDUS [38]. Using this CDUS vessel sig-
nal, thoracic lesions with at least a detectable CDUS
“pulmonary artery vessel signal” were considered to
be benign. In a study lasting more than 6 years, we
screened and analyzed 264 thoracic lesions (125
lung cancers and 139 benign lesions) and found that
the CDUS “pulmonary artery vessel signal” was reli-
able in predicting and differentiating benign lesions
from lung cancers (p < 0.0001; sensitivity, 0.53 [74/
139]; specificity, 0.98 [123/125]; positive likelihood
ratio, 26.5) (Figs. 3 and 4). Only two specific alveolar
cell carcinomas with lobar consolidation presented
with a CDUS “pulmonary artery vessel signal”; these
were the only exceptions among the lung cancers.
Our results suggest that the CDUS “pulmonary artery
vessel signal” deserves a wide clinical application in
predicting benign pulmonary lesions [38].
CDUS “Fluid Color Sign” to Assess the
Thoracocentesis of Minimal Pleural Effusion
Chest US can be used to assess minimal pleural effu-
sion and guide thoracocentesis. However, CDUS can
be more useful than grayscale US in predicting the
success of thoracocentesis of minimal pleural effu-
sion. Respiratory movement will cause the minimal
pleural effusion to move and create a color signal
under CDUS. Wu et al reported this finding as 
a CDUS “fluid color sign” and proved it to be more
sensitive than grayscale US in predicting the success
of thoracocentesis (Fig. 5) [23,25].
Loculated pleural effusion, however, will not pres-
ent with a CDUS “fluid color sign,” even if it can
be aspirated smoothly. Therefore, the CDUS “fluid
color sign” is not present and cannot be applied to
localized and loculated pleural effusions.
Diagnosis of Specific Vascular Anomalies 
and Utility for Tissue Differentiation
Pulmonary sequestration is a congenital malfor-
mation with non-functioning lung tissue that is
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supplied by an aberrant systemic artery. Hernanz-
Schulman et al reported that CDUS can demonstrate the
aberrant systemic artery supplying the abnormal lung
tissue, and then diagnose pulmonary sequestration
smoothly [26]. In our limited experience, the aber-
rant systemic artery that supplies the pulmonary
sequestration is sometimes easily found by CDUS,
but this task generally proves difficult (Fig. 6).
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Fig. 2. (A) Chest radiograph shows a mass in the left upper lobe. Squamous cell carcinoma was diagnosed by ultrasound-guided
fine-needle aspiration. (B) Bronchial arteriogram shows that the tumor was supplied by the bronchial arteries, originating from the
same level as the right bronchial artery. However, the vessels within the tumor were torturous, small, and irregular (without pre-
dictable direction). (C) Color Doppler ultrasound demonstrated only a small short segment of pulsatile flows within the tumor. (D)
Pulmonary angiogram shows the pulmonary arteries running smoothly and regularly.
A B
Fig. 3. (A) Chest radiography shows a mass-like lesion in the right middle lung field. (B) Color Doppler ultrasound reveals pulsatile flow
within the lesion with the “pulmonary artery vessel signal” present. The pulmonary lesion completely resolved after antibiotic treatment.
Pulmonary arteriovenous malformation is occa-
sionally encountered by chest physicians. Chest
radiograph, computed tomography, and pulmonary
angiography are all valuable in this regard and pro-
vide the potential to detect vascular malformation.
However, CDUS provides a real-time, noninvasive and
convenient imaging modality in rapidly diagnosing
pulmonary arteriovenous malformation (Fig. 7) [22].
For specific vascular lesions, CDUS undoubtedly
has a more powerful imaging function and greater
W.H. Hsu




Fig. 4. (A) Chest radiograph shows fibroproductive infiltrations
in the bilateral upper lung fields, and active pulmonary tubercu-
losis was considered. (B) After a 1-month chemotherapy for tuber-
culosis, the chest radiograph shows a large mass with cavitation
in the left upper lobe. (C) Thoracic computed tomography also
clearly demonstrates central necrosis in the mass lesion. Clinically,
lung cancer was highly suspected. (D) Grayscale ultrasound also
reveals a well-defined mass-like lesion at the left upper lobe. (E)
However, power Doppler ultrasound could easily demonstrate
the prominent vessels with the “pulmonary artery vessel signal,”
using waveform analysis. After continuing chemotherapy for
tuberculosis for 6 months, the patient’s condition improved, with
only residual lesions on his follow-up chest radiograph.
potential than grayscale US in assessing and diag-
nosing vascular anomalies (Figs. 6 and 7). In some
specific uncommon thoracic lesions, CDUS can
diagnose the underlying diseases and differentiate
the tissue characteristics solely on the basis of
information from its imaging vessel signals (Fig. 8).
CDUS Equipped with a Color-based 
Puncture-guiding Device
Though CDUS can readily demonstrate vessel signals
within lesions, CDUS equipped with a color-based
puncture-guiding device is useful in guiding nee-
dle biopsy, especially in cases of pulmonary consoli-
dation and mediastinal tumors (Fig. 9). Wang et al
compared grayscale US-guided needle biopsy with
CDUS-guided needle biopsy [28] and found that
the diagnostic results and associated complications
were similar; however, visualization of blood vessels
was more common with CDUS than grayscale US 
(p < 0.05). Clinically, CDUS equipped with a color-
based puncture-guiding device can easily demon-
strate the prominent vessels and confidently guide
transthoracic needle biopsy [28,29].
PDUS in the Detection of Vessel Signals
Conventional CDUS has a number of limitations in
assessing vessel signals in thoracic lesions, including
the insonating angle, flow velocity, US probe, anat-
omic narrowing interface, and the necessity of 
patient cooperation. Of these, the limitations in
Color Doppler Ultrasound in Chest Medicine
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Fig. 5. Color Doppler ultrasound “fluid color sign” is present
in a patient with left pleural effusion, which indicates that tho-
racocentesis should be successful.
Fig. 6. Color Doppler ultrasound shows the aberrant systemic
artery originating from the aorta (arrow) and supplying the
consolidated lung.
Fig. 7. (A) Grayscale ultrasound only shows a large anechoic lesion. (B) Color Doppler ultrasound reveals turbulent vessel signal
within the lesion; a large pulmonary arteriovenous malformation was confirmed.
detecting vessels with slow flow and the influence
of the insonating angle are the main concerns in
CDUS [17].
PDUS (or US angiography) has overcome some
of the main limitations of CDUS, especially the influ-
ence of the insonating angle. In the literature,
PDUS is reported to be angle-independent, more
sensitive in detecting vessels with slow flow, and
have less aliasing [19,20]. In our experience, PDUS
is commonly more sensitive in the detection and
illustration of vessel signals than conventional CDUS
(Fig. 10). Nevertheless, the clinical application of
PDUS in chest medicine requires further study.
DFUS in the Illustration of Vessel Signals
CDUS and PDUS can readily produce blooming
effects of vessels and color noise in demonstrating
lesions that abut pulsatile organs [17,25]. The bloom-
ing effect of vessels renders the US assessment of
vessel signals less real, and color noise lowers con-
fidence in the US demonstration of vessel signals.
For vessel signals in thoracic lesions, both CDUS and
PDUS often produce more prominent blooming
effects and color noises because of the respiratory
movement of the lung, diaphragm, and pulsatile or-
gans within the thorax. Therefore, the use of CDUS
and PDUS in the assessment of vessel signals in
thoracic lesions is always difficult.
DFUS is a newly developed color Doppler im-
aging method reported to provide better B-mode
imaging with fewer blooming effects and color
noises, compared with those of conventional CDUS
and PDUS [30,31,39,40]. Clinically, we have used
DFUS, CDUS, and PDUS to evaluate the vessel signals
in 34 thoracic lesions abutting pulsatile organs and
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Fig. 8. (A) Grayscale ultrasound only discloses a typical complex-septated pleural effusion. (B) Color Doppler ultrasound (CDUS)
demonstrates venous flows within the septa; tumor with central necrosis was suspected. (C) Computed tomography confirmed the
diagnosis to be the same as the CDUS findings.
Fig. 9. The color Doppler ultrasound puncture device has the
advantages of adjusted angle selection for needle biopsy, and
detects the prominent vessels easily, thereby preventing the
possible complication of injury to the great vessels.
compared the imaging quality of the vessel signals
in different US modes. Our preliminary results
showed that DFUS, CDUS, and PDUS could all
demonstrate the vessel signals clearly (all p > 0.05).
However, when focusing on the blooming effect
and color noise, DFUS showed superior imaging
quality to CDUS and PDUS (all p≤0.001) (Fig. 11).
In the assessment of decision making for percuta-
neous needle biopsy in particular, DFUS had less
influence than CDUS and PDUS (both p < 0.01) [41].
Therefore, DFUS clearly has a superior imaging
quality to CDUS and PDUS in demonstrating the
Color Doppler Ultrasound in Chest Medicine
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Fig. 10. (A) Traditional color Doppler ultrasound only shows pulmonary venous flow within the lesion. (B) Power Doppler ultra-




Fig. 11. (A) Grayscale ultrasound (US) shows a hypoechoic lesion. (B) Tissue harmonic imaging also discloses a hypoechoic lesion.
(C) Color Doppler ultrasound shows the vessel signals with a blooming effect apparent within the lesion. (D) Power Doppler US
also detects the vessel signals with a prominent blooming effect. (E) Dynamic flow US illustrates the vessel signals without the
blooming effect.
vessel signals of thoracic lesions, with less blooming
effect and color noise. Larger studies are necessary
in the future to confirm our results.
Conclusion
Chest US examination and US-guided needle biopsy
have become useful diagnostic tools in clinical prac-
tice. The application of CDUS further extends the
potential function, clinical utility, and uses in research
of US in chest medicine. CDUS renders the US ex-
amination safer and more confident and prevents
possible injury to great vessels. The development of
PDUS (US angiography) improves the illustration of
vessel signals without angle limitation, and newly
developed DFUS exhibits superior imaging quality
with reduced color noise and blooming effect. The
broad applications of CDUS in thoracic diseases have
made CDUS a clinically powerful and necessary im-
aging modality, especially in guiding transthoracic
percutaneous needle biopsy of thoracic lesions. We
believe that CDUS will be widely applied in chest
medicine in the future.
References
1. Westcott JL. Direct percutaneous needle aspiration
of localized pulmonary lesions: result in 422 patients.
Radiology 1980;137:31–5.
2. Khouri NF, Stitik FP, Erozan YS, et al. Transthoracic
needle aspiration biopsy of benign and malignant lung
lesions. AJR Am J Roentgenol 1985;144:281–8.
3. van Sonnenberg E, Casola G, Ho M, et al. Difficult
thoracic lesions: CT-guided biopsy experience in 150
cases. Radiology 1988;167:457–61.
4. Westcott JL. Percutaneous transthoracic needle biopsy.
Radiology 1988;169:593–601.
5. Izumi S, Tamaki S, Natori H, et al. Ultrasonically
guided aspiration needle biopsy in disease of the chest.
Am Rev Respir Dis 1982;125:460–4.
6. Ikezoe J, Morimoto S, Arisawa J, et al. Percutaneous
biopsy of thoracic lesions: value of sonography for
needle guidance. AJR Am J Roentgenol 1990;154:
1181–5.
7. Yang PC, Chang DB, Yu CJ, et al. Ultrasound-guided
core biopsy of thoracic tumors. Am Rev Respir Dis
1992;146:763–7.
8. Saito T, Kobayashi H, Sugama Y, et al. Ultrasonically
guided needle biopsy in the diagnosis of mediastinal
masses. Am Rev Respir Dis 1988;138:679–84.
9. Sugama Y, Tamaki S, Kitamura S, et al. Ultrasonog-
raphic evaluation of pleural and chest wall invasion
of lung cancer. Chest 1988;93:275–9.
10. Suzuki N, Saitoh T, Kitamura S. Tumor invasion of the
chest wall in lung cancer: diagnosis with US. Radiology
1993;187:39–42.
11. Hsu WH, Chiang CD, Hsu JY, et al. Ultrasound-guided
fine-needle aspiration biopsy of lung cancers. J Clin
Ultrasound 1996;24:225–33.
12. Yang PC, Luh KT, Chang DB, et al. Ultrasonographic
evaluation of pulmonary consolidation. Am Rev Respir
Dis 1992;146:757–62.
13. Taylor KJW, Ramos I, Carter D, et al. Correlation of
Doppler US tumor signals with neovascular morpho-
logic features. Radiology 1988;166:57–62.
14. Cosgrove DO, Bamber JC, Davey JB, et al. Color
Doppler signals from breast tumors. Radiology 1990;
176:175–80.
15. Tanaka S, Kitamura T, Fujita M, et al. Color Doppler
flow imaging of liver tumors. AJR Am J Roentgenol
1990;154:509–14.
16. Wu CC, Lee CN, Chen TM, et al. Incremental angio-
genesis assessed by color Doppler ultrasound in the
tumorigenesis of ovarian neoplasms. Cancer 1994;73:
1251–6.
17. Foley WD, Erickson SJ. Color Doppler flow imaging.
AJR Am J Roentgenol 1991;156:3–13.
18. Horstman WG, Middleton WD, Melson GL. Scrotal
inflammatory disease: color Doppler US findings.
Radiology 1991;179:55–9.
19. Rubin JM, Bude RO, Carson PL, et al. Power Doppler
US: a potentially useful alternative to mean frequency-
based color Doppler US. Radiology 1994;190:853–6.
20. Bude RO, Rubin JM, Adler RS. Power versus conven-
tional color Doppler sonography: comparison in the
depiction of normal intrarenal vasculature. Radiology
1994;192:777–80.
21. Hsu WH, Ikezoe J, Chen CY, et al. Color Doppler
ultrasound signals of thoracic lesions: correlation with
resected histologic specimens. Am J Respir Crit Care Med
1996;153:1938–51.
22. Kuo PH, Yuan A, Yang PC, et al. Diagnosis of pulmo-
nary arteriovenous malformation with color Doppler
ultrasonography. J Ultrasound Med 1995;14:53–6.
W.H. Hsu
150 J Med Ultrasound 2007 • Vol 15 • No 3
23. Wu RG, Yuan A, Liaw YS, et al. Image comparison of
real-time gray-scale ultrasound and color Doppler
ultrasound for use in diagnosis of minimal pleural
effusion. Am J Respir Crit Care Med 1994;150:510–4.
24. Yuan A, Chang DB, Yu CJ, et al. Color Doppler sonog-
raphy of benign and malignant pulmonary masses.
AJR Am J Roentgenol 1994;163:545–9.
25. Wu RG, Yang PC, Kuo SH, et al. “Fluid color” sign: 
a useful indicator for discrimination between pleural
thickening and pleural effusion. J Ultrasound Med 1995;
14:767–9.
26. Hernanz-Schulman M, Stein SM, Neblett WW, et al.
Pulmonary sequestration: diagnosis with color Doppler
sonography and a new theory of associated hydrotho-
rax. Radiology 1991;180:817–21.
27. Hsu WH, Chiang CD, Chen CY, et al. Color Doppler
ultrasound pulsatile flow signals of thoracic lesions:
comparison of lung cancers and benign lesions.
Ultrasound Med Biol 1998;24:1087–95.
28. Wang HC, Yu CJ, Chang DB, et al. Transthoracic nee-
dle biopsy of thoracic tumours by a colour Doppler
ultrasound puncture guiding device. Thorax 1995;50:
1258–63.
29. Hsu WH, Chiang CD, Chen CY, et al. Ultrasound-
guided fine needle aspiration biopsy in the diagnosis
of chronic pulmonary infection. Respiration 1997;64:
319–25.
30. Sato T. Technological description of dynamic flow.
Toshiba Med Rev 2001;25:29–33. [In Japanese]
31. Miyashita S. Evaluation of the fetal circulation and
veins. Toshiba Med Rev 2002;56:750–6. [In Japanese]
32. Laing FC, Filly RA. Problems in the application of
ultrasonography for the evaluation of pleural opaci-
ties. Radiology 1978;126:211–4.
33. Hirsch JH, Rogers JV, Mack LA. Real-time sonography
of pleural opacities. AJR Am J Roentgenol 1981;136:
297–301.
34. Kier R, Taylor KJW, Feyock AL, et al. Renal masses:
characterization with Doppler US. Radiology 1990;176:
703–7.
35. Shimamoto K, Sakuma S, Ishigaki T, et al. Hepa-
tocellular carcinoma: evaluation with color Doppler
US and MR imaging. Radiology 1992;182:149–53.
36. Kuijpers D, Jaspers R. Renal masses: differential diag-
nosis with pulsed Doppler US. Radiology 1989;170:
59–60.
37. Gorg C, Seifart U, Gorg K, et al. Color Doppler sono-
graphic mapping of pulmonary lesions: evidence of
dual arterial supply by spectral analysis. J Ultrasound
Med 2003;22:1033–9.
38. Hsu WH, Yu YH, Tu CY, et al. Color Doppler US 
pulmonary artery vessel signal: a sign for predicting
the benign lesions. Ultrasound Med Biol 2007;33:
379–88.
39. Hotta N, Tagaya T, Maeno T, et al. Usefulness of
contrast-enhanced ultrasonography with dynamic flow
imaging to evaluate therapeutic effects for hepatocellu-
lar carcinoma. Hepato-gastroenterology 2003;50:1867–71.
40. Hotta N, Tagaya T, Maeno T, et al. Advanced dynamic
flow imaging with contrast-enhanced ultrasonogra-
phy for the evaluation of tumor vascularity in liver
tumors. J Clin Imag 2005;29:34–41.
41. Hsu WH, Tu CY, Chen HJ, et al. Vessel signals of 
thoracic lesions abutting pulsatile organs: assessment
by dynamic flow US, color Doppler US, and power
Doppler US [abstract]. Annual Meeting of ATS
International Conference, San Diego, California, USA,
2006:A704.
Color Doppler Ultrasound in Chest Medicine
151J Med Ultrasound 2007 • Vol 15 • No 3
